Matched population comparison of the visian implantable collamer lens and standard LASIK for myopia of -3.00 to -7.88 diopters

Journal of Refractive Surgery

Volumn 23, Issue 6, 2007, Pages 537-553

  Sanders, Donald R ^a  

^a Center for Clinical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; FEMALE; HUMAN; KERATOMILEUSIS; LENS IMPLANT; MAJOR CLINICAL STUDY; MALE; MYOPIA; OBSERVATIONAL STUDY; POPULATION RESEARCH; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SAFETY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UNITED STATES; VISUAL ACUITY;

EID: 34250634721     PISSN: 1081597X     EISSN: None     Source Type: Journal    
DOI: 10.3928/1081-597x-20070601-02     Document Type: Article

References (47)

1. Sanders DR, Doney K, Poco M; ICL in Treatment of Myopia Study Group. United States Food and Drug Administration clinical trial of the implantable collamer lens (ICL) for moderate to high myopia; three year follow-up. Ophthalmology. 2004;111:1683-1692.
2. Sanders DR, Vukich JA, Doney K, Gaston M; Implantable Contact Lens in Treatment of Myopia Study Group. U.S. Food and Drug Administration clinical trial of the Implantable Contact Lens for moderate to high myopia. Ophthalmology. 2003;110:255-266.
3. Sanders DR, Vukich JA. Comparison of implantable contact lens and laser assisted in situ keratomileusis for moderate to high myopia. Cornea. 2003;22:324-331.
4. Sanders DR, Vukich JA. Comparison of implantable collamer lens (ICLTM) and laser assisted in situ keratomileusis (LASIK) for low myopia. Cornea. In press.
5. Sarver EJ, Sanders DR. Astigmatic power calculations for intraocular lenses in the phakic and aphakic eye. J Refract Surg. 2004;20:472-477.
6. U.S. Food and Drug Administration, Center for Devices and Radiological Health. Premarket Approval Application (PMA) summary of safety and effectiveness data (PMA P930016/S016). VISX STAR S4 excimer laser system. Rockville, MD: Center for Devices and Radiological Health; 2003. Available at: http://www.fda.gov/cdrh/pdf/P930016S016.html.
7. U.S. Food and Drug Administration, Center for Devices and Radiological Health. Premarket Approval Application (PMA) summary of safety and effectiveness data (PMA P930016/S021). VISX STAR S4 excimer laser system. Rockville, MD: Center for Devices and Radiological Health; 2003. Available at: http:// www.fda.gov/cdrh/pdf/P930016S021.html.
8. U.S. Food and Drug Administration, Center for Devices and Radiological Health. Premarket Approval Application (PMA) summary of safety and effectiveness data (PMA P970043/ S015). Alcon Laboratories Inc LADARVision4000 excimer laser system. Rockville, MD: Center for Devices and Radiological Health; 2003. Available at: http://www.fda.gov/cdrh/pdf/ P970043S015.html.
9. Twa MD, Lembach RG, Bullimore MA, Roberts C. A prospective randomized clinical trial of laser in situ keratomileusis with two different lasers. Am J Ophthalmol. 2005;140:173-183.
10. Seward MS, Oral D, Bowman RW, El-Agha MS, Cavanagh HD, McCulley JP. Comparison of LADARVision and Visx Star S3 laser in situ keratomileusis outcomes in myopia and hyperopia. J Cataract Refract Surg. 2003;29:2351-2357.
11. Giaconi JA, Manche EE. Ablation centration in myopic laser in situ keratomileusis, comparing the Visx S3 ActiveTrak and the Visx S2. J Cataract Refract Surg. 2003;29:1522-1529.
12. Balazsi G, Mullie M, Lasswell L, Lee PA, Duh YJ. Laser in situ keratomileusis with a scanning excimer laser for the correction of low to moderate myopia with and without astigmatism. J Cataract Refract Surg. 2001;27:1942-1951.
13. Fraunfelder FW, Rich LF. Laser in situ keratomileusis using the Nidek EC-5000 or the Alcon LADARVision 4000 systems. J Refract Surg. 2004;20:127-131.
14. Caster AI, Hoff JL, Ruiz R. Conventional vs wavefront-guided LASIK using the LADARVision4000 excimer laser. J Refract Surg. 2005;21:S786-S791.
15. Goes FJ. LASIK for myopia with the Zeiss Meditec MEL 80. J Refract Surg. 2005;21:691-697.
16. Lin JM, Tsai YY. Laser in situ keratomileusis for different degrees of myopia. Acta Ophthalmol Scand. 2005;83:40-45.
17. Nuijts RM, Nabar VA, Hament WJ, Eggink FA. Wavefront-guided versus standard laser in situ keratomileusis to correct low to moderate myopia. J Cataract Refract Surg. 2002;28:1907-1913.
18. Johnson JD, Harissi-Dagher M, Pineda R, Yoo S, Azar DT. Diffuse lamellar keratitis: incidence, associations, outcomes, and a new classification system. J Cataract Refract Surg. 2001;27:1560-1566.
19. Hoffman RS, Fine IH, Packer M. Incidence and outcomes of LASIK with diffuse lamellar keratitis treated with topical and oral corticosteroids. J Cataract Refract Surg. 2003;29:451-456.
20. Wilson SE, Ambrosio R. Sporadic diffuse lamellar keratitis (DLK) after LASIK. Cornea. 2002;21:560-563.
21. Stulting RD, Randleman JB, Couser JM, Thompson KP. The epidemiology of diffuse lamellar keratitis. Cornea. 2004;23:680-688.
22. Mamalis N. Diffuse lamellar keratitis. J Cataract Refract Surg. 2003;29:1849-1850.
23. Thammano P, Rana AN, Talamo JH. Diffuse lamellar keratitis after laser in situ keratomileusis with the Moria LSK-One and Carriazo-Barraquer microkeratomes. J Cataract Refract Surg. 2003;29:1962-1968.
24. Yuhan KR, Nguyen L, Wachler BS. Role of instrument cleaning and maintenance in the development of diffuse lamellar keratitis. Ophthalmology. 2002;109:400-404.
25. Holland SP, Mathias RG, Morck DW, Chiu J, Slade SG. Diffuse lamellar keratitis related to endotoxins released from sterilizer reservoir biofilms. Ophthalmology. 2000;107:1227-1234.
26. Lin RT, Maloney RK. Flap complications associated with lamellar refractive surgery. Am J Ophthalmol. 1999;127:129-136.
27. Levinger S, Landau D, Kremer I, Merin S, Aizenman I, Hirsch A, Douieb J, Bos T. Wiping microkeratome blades with sterile 100% alcohol to prevent diffuse lamellar keratitis after laser in situ keratomileusis. J Cataract Refract Surg. 2003;29:1947-1949.
28. Tham VM, Maloney RK. Microkeratome complications of laser in situ keratomileusis. Ophthalmology. 2000;107:920-924.
29. Gimbel HV, Penno EE, van Westenbrugge JA, Ferensowicz M, Furlong MT. Incidence and management of intraoperative and early postoperative complications in 1000 consecutive laser in situ keratomileusis cases. Ophthalmology. 1998;105:1839-1848.
30. Pannu JS. Incidence and treatment of wrinkled corneal flap following LASIK. J Cataract Refract Surg. 1997;23:695-696.
31. Gimbel HV, Basti S, Kaye GB, Ferensowicz M. Experience during the learning curve of laser in situ keratomileusis. J Cataract Refract Surg. 1996;22:542-550.
32. von Kulajta P, Stark WJ, O'Brien TP. Management of flap striae. Int Ophthalmol Clin. 2000;40:87-92.
33. Jin GJ, Lyle WA, Merkley KH. Laser in situ keratomileusis for primary hyperopia. J Cataract Refract Surg. 2005;31:776-784.
34. Kremer I, Bahar I, Hirsh A, Levinger S. Clinical outcome of wavefront-guided laser in situ keratomileusis in eyes with moderate to high myopia with thin corneas. J Cataract Refract Surg. 2005;31:1366-1371.
35. O'Brart DP, Patsoura E, Jaycock P, Rajan M, Marshall J. Excimer laser photorefractive keratectomy for hyperopia: 7.5-year follow-up. J Cataract Refract Surg. 2005;31:1104-1113.
36. Twa MD, Roberts C, Mahmoud AM, Chang JS Jr. Response of the posterior corneal surface to laser in situ keratomileusis for myopia. J Cataract Refract Surg. 2005;31:61-71.
37. Macsai MS, Stubbe K, Beck AP, Ravage ZB. Effect of expanding the treatment zone of the Nidek EC-5000 laser on laser in situ keratomileusis outcomes. J Cataract Refract Surg. 2004;30:2336-2343.
38. Rajan MS, Jaycock P, O'Brart D, Nystrom HH, Marshall J. A long-term study of photorefractive keratectomy: 12-year follow-up. Ophthalmology. 2004;111:1813-1824.
39. Kamiya K, Miyata K, Tokunaga T, Kiuchi T, Hiraoka T, Oshika T. Structural analysis of the cornea using scanning-slit corneal topography in eyes undergoing excimer laser refractive surgery. Cornea. 2004;23:S59-S64.
40. Miyata K, Tokunaga T, Nakahara M, Ohtani S, Nejima R, Kiuchi T, Kaji Y, Oshika T. Residual bed thickness and corneal forward shift after laser in situ keratomileusis. J Cataract Refract Surg. 2004;30:1067-1072.
41. Sekundo W, Bonicke K, Mattausch P, Wiegand W. Six-year follow-up of laser in situ keratomileusis for moderate and extreme myopia using a first-generation excimer laser and microkeratome. J Cataract Refract Surg. 2003;29:1152-1158.
42. Agarwal A, Agarwal A, Agarwal T, Bagmar A, Agarwal S. Laser in situ keratomileusis for residual myopia after primary LASIK. J Cataract Refract Surg. 2001;27:1013-1017.
43. Magallanes R, Shah S, Zadok D, Chayet AS, Assil K, Montes M, Robledo N. Stability after laser in situ keratomileusis in moderately and extremely myopic eyes. J Cataract Refract Surg. 2001;27:1007-1012.
44. Pallikaris IG, Kymionis GD, Astyrakakis NI. Corneal ectasia induced by laser in situ keratomileusis. J Cataract Refract Surg. 2001;27:1796-1802.
45. Oshima Y, Tsujikawa K, Oh A, Harino S. Comparative study of intraocular lens implantation through 3.0 mm temporal clear corneal and superior scleral tunnel self-sealing incisions. J Cataract Refract Surg. 1997;23:347-353.
46. Ermis SS, Inan UU, Ozturk F. Surgically induced astigmatism after superotemporal and superonasal clear corneal incisions in phacoemulsification. J Cataract Refract Surg. 2004;30:1316-1319.
47. Sarver EJ, Sanders DR, Vukich JA. Image quality in myopic eyes corrected with laser in situ keratomileusis and phakic intraocular lens. J Refract Surg. 2003;19:397-404.